vs
Harmony Biosciences Holdings, Inc.（HRMY）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
Harmony Biosciences Holdings, Inc.的季度营收约是GIBRALTAR INDUSTRIES, INC.的1.1倍（$243.8M vs $225.0M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs 21.1%），Harmony Biosciences Holdings, Inc.自由现金流更多（$126.0M vs $26.2M），过去两年Harmony Biosciences Holdings, Inc.的营收复合增速更高（25.6% vs -12.3%）
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
HRMY vs ROCK — 直观对比
营收规模更大
HRMY
是对方的1.1倍
$225.0M
营收增速更快
ROCK
高出3.8%
21.1%
自由现金流更多
HRMY
多$99.8M
$26.2M
两年增速更快
HRMY
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $243.8M | $225.0M |
| 净利润 | $22.5M | — |
| 毛利率 | 71.9% | 25.3% |
| 营业利润率 | 15.8% | 7.9% |
| 净利率 | 9.2% | — |
| 营收同比 | 21.1% | 24.9% |
| 净利润同比 | -54.6% | — |
| 每股收益（稀释后） | $0.38 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRMYROCK
| Q4 25 | $243.8M | $225.0M | ||
| Q3 25 | $239.5M | $310.9M | ||
| Q2 25 | $200.5M | $309.5M | ||
| Q1 25 | $184.7M | $290.0M | ||
| Q4 24 | $201.3M | $180.1M | ||
| Q3 24 | $186.0M | $277.1M | ||
| Q2 24 | $172.8M | $273.6M | ||
| Q1 24 | $154.6M | $292.5M |
净利润HRMYROCK
| Q4 25 | $22.5M | — | ||
| Q3 25 | $50.9M | $-89.1M | ||
| Q2 25 | $39.8M | $26.0M | ||
| Q1 25 | $45.6M | $21.1M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $46.1M | $34.0M | ||
| Q2 24 | $11.6M | $32.2M | ||
| Q1 24 | $38.3M | $24.9M |
毛利率HRMYROCK
| Q4 25 | 71.9% | 25.3% | ||
| Q3 25 | 75.1% | 26.6% | ||
| Q2 25 | 81.0% | 28.4% | ||
| Q1 25 | 82.7% | 26.8% | ||
| Q4 24 | 73.0% | 29.0% | ||
| Q3 24 | 77.0% | 29.4% | ||
| Q2 24 | 81.4% | 30.5% | ||
| Q1 24 | 82.2% | 28.9% |
营业利润率HRMYROCK
| Q4 25 | 15.8% | 7.9% | ||
| Q3 25 | 27.3% | 12.8% | ||
| Q2 25 | 24.0% | 12.8% | ||
| Q1 25 | 30.4% | 8.8% | ||
| Q4 24 | 27.7% | 13.3% | ||
| Q3 24 | 33.2% | 15.6% | ||
| Q2 24 | 12.4% | 14.9% | ||
| Q1 24 | 33.7% | 10.8% |
净利率HRMYROCK
| Q4 25 | 9.2% | — | ||
| Q3 25 | 21.2% | -28.6% | ||
| Q2 25 | 19.8% | 8.4% | ||
| Q1 25 | 24.7% | 7.3% | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 24.8% | 12.3% | ||
| Q2 24 | 6.7% | 11.8% | ||
| Q1 24 | 24.8% | 8.5% |
每股收益（稀释后）HRMYROCK
| Q4 25 | $0.38 | — | ||
| Q3 25 | $0.87 | $-2.98 | ||
| Q2 25 | $0.68 | $0.87 | ||
| Q1 25 | $0.78 | — | ||
| Q4 24 | $0.85 | — | ||
| Q3 24 | $0.79 | $1.11 | ||
| Q2 24 | $0.20 | $1.05 | ||
| Q1 24 | $0.67 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $775.3M | $115.7M |
| 总债务越低越好 | $163.7M | $0 |
| 股东权益账面价值 | $870.2M | $950.4M |
| 总资产 | $1.3B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资HRMYROCK
| Q4 25 | $775.3M | $115.7M | ||
| Q3 25 | $672.6M | $89.4M | ||
| Q2 25 | $565.3M | $43.3M | ||
| Q1 25 | $507.0M | $25.1M | ||
| Q4 24 | $467.2M | $269.5M | ||
| Q3 24 | $410.5M | $228.9M | ||
| Q2 24 | $346.9M | $179.1M | ||
| Q1 24 | $372.4M | $146.7M |
总债务HRMYROCK
| Q4 25 | $163.7M | $0 | ||
| Q3 25 | $168.5M | $0 | ||
| Q2 25 | $172.1M | $0 | ||
| Q1 25 | $175.7M | $0 | ||
| Q4 24 | $179.3M | $0 | ||
| Q3 24 | $182.8M | $0 | ||
| Q2 24 | $186.4M | $0 | ||
| Q1 24 | $190.0M | $0 |
股东权益HRMYROCK
| Q4 25 | $870.2M | $950.4M | ||
| Q3 25 | $835.1M | $951.8M | ||
| Q2 25 | $773.1M | $1.0B | ||
| Q1 25 | $720.5M | $1.0B | ||
| Q4 24 | $659.2M | $1.0B | ||
| Q3 24 | $596.8M | $1.0B | ||
| Q2 24 | $538.6M | $975.7M | ||
| Q1 24 | $515.4M | $940.2M |
总资产HRMYROCK
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $999.2M | $1.4B | ||
| Q3 24 | $928.1M | $1.4B | ||
| Q2 24 | $858.4M | $1.4B | ||
| Q1 24 | $847.0M | $1.3B |
负债/权益比HRMYROCK
| Q4 25 | 0.19× | 0.00× | ||
| Q3 25 | 0.20× | 0.00× | ||
| Q2 25 | 0.22× | 0.00× | ||
| Q1 25 | 0.24× | 0.00× | ||
| Q4 24 | 0.27× | 0.00× | ||
| Q3 24 | 0.31× | 0.00× | ||
| Q2 24 | 0.35× | 0.00× | ||
| Q1 24 | 0.37× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.2M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $126.0M | $26.2M |
| 自由现金流率自由现金流/营收 | 51.7% | 11.7% |
| 资本支出强度资本支出/营收 | 0.0% | 4.1% |
| 现金转化率经营现金流/净利润 | 5.61× | — |
| 过去12个月自由现金流最近4个季度 | $347.9M | $120.6M |
8季度趋势，按日历期对齐
经营现金流HRMYROCK
| Q4 25 | $126.2M | $35.5M | ||
| Q3 25 | $108.7M | $73.0M | ||
| Q2 25 | $79.3M | $44.9M | ||
| Q1 25 | $34.0M | $13.7M | ||
| Q4 24 | $75.6M | $19.9M | ||
| Q3 24 | $70.5M | $64.7M | ||
| Q2 24 | $42.6M | $36.5M | ||
| Q1 24 | $31.1M | $53.2M |
自由现金流HRMYROCK
| Q4 25 | $126.0M | $26.2M | ||
| Q3 25 | $108.7M | $64.8M | ||
| Q2 25 | $79.3M | $27.3M | ||
| Q1 25 | $33.9M | $2.3M | ||
| Q4 24 | $75.0M | $14.1M | ||
| Q3 24 | $70.5M | $60.5M | ||
| Q2 24 | $42.0M | $33.5M | ||
| Q1 24 | $31.1M | $48.8M |
自由现金流率HRMYROCK
| Q4 25 | 51.7% | 11.7% | ||
| Q3 25 | 45.4% | 20.8% | ||
| Q2 25 | 39.6% | 8.8% | ||
| Q1 25 | 18.3% | 0.8% | ||
| Q4 24 | 37.3% | 7.8% | ||
| Q3 24 | 37.9% | 21.8% | ||
| Q2 24 | 24.3% | 12.2% | ||
| Q1 24 | 20.1% | 16.7% |
资本支出强度HRMYROCK
| Q4 25 | 0.0% | 4.1% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 5.7% | ||
| Q1 25 | 0.1% | 3.9% | ||
| Q4 24 | 0.3% | 3.3% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | 0.4% | 1.1% | ||
| Q1 24 | 0.0% | 1.5% |
现金转化率HRMYROCK
| Q4 25 | 5.61× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.99× | 1.73× | ||
| Q1 25 | 0.75× | 0.65× | ||
| Q4 24 | 1.53× | — | ||
| Q3 24 | 1.53× | 1.90× | ||
| Q2 24 | 3.68× | 1.13× | ||
| Q1 24 | 0.81× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRMY
暂无分部数据
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
